首页> 美国卫生研究院文献>other >INFLUENCE OF IRON CHELATION ON R1 AND R2 CALIBRATION CURVES IN GERBIL LIVER AND HEART
【2h】

INFLUENCE OF IRON CHELATION ON R1 AND R2 CALIBRATION CURVES IN GERBIL LIVER AND HEART

机译:铁含量的变化对啤酒肝脏和心脏R1和R2校准曲线的影响

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

MRI is gaining increasing importance for the noninvasive quantification of organ iron burden. Since transverse relaxation rates depend on iron distribution as well as iron concentration, physiologic and pharmacologic processes that alter iron distribution could change MRI calibration curves. This paper compares the effect of three iron chelators, deferoxamine, deferiprone, and deferasirox on R1 and R2 calibration curves according to two iron loading and chelation strategies. 33 Mongolian gerbils underwent iron loading (iron dextran 500 mg/kg/wk) for 3 weeks followed by 4 weeks of chelation. An additional 56 animals received less aggressive loading (200 mg/kg/week) for 10 weeks, followed by 12 weeks of chelation. R1 and R2 calibration curves were compared to results from 23 iron-loaded animals that had not received chelation. Acute iron loading and chelation biased R1 and R2 from the unchelated reference calibration curves but chelator-specific changes were not observed, suggesting physiologic rather than pharmacologic differences in iron distribution. Long term chelation deferiprone treatment increased liver R1 50% (p<0.01), while long term deferasirox lowered liver R2 30.9% (p<0.0001). The relationship between R1 and R2 and organ iron concentration may depend upon the acuity of iron loading and unloading as well as the iron chelator administered.
机译:MRI对于非侵入性量化器官铁负荷越来越重要。由于横向弛豫率取决于铁分布以及铁浓度,因此改变铁分布的生理和药理过程可能会改变MRI校准曲线。本文根据两种铁负载和螯合策略,比较了三种铁螯合剂,去铁胺,去铁酮和去铁胺对R1和R2校准曲线的影响。对33只蒙古沙鼠进行了3周的铁负载(右旋糖酐铁500 mg / kg / wk),然后进行了4周的螯合。另外56只动物在10周内受到较少的侵害负荷(200mg / kg /周),随后是12周的螯合。将R1和R2校准曲线与23只未螯合铁的动物的结果进行比较。急性铁负荷和螯合使未螯合的参考校正曲线上的R1和R2发生偏倚,但未观察到螯合剂特异性的变化,表明铁分布的生理差异而非药理差异。长期螯合去铁酮治疗可增加肝脏R1 50%(p <0.01),而长期地拉罗司降低肝脏R2 30.9%(p <0.0001)。 R1和R2与器官铁浓度之间的关系可能取决于铁的装载和卸载的敏锐度以及所施用的铁螯合剂。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号